Search Results - "Kaza, Michal"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse? by Kaza, Michał, Karaźniewicz-Łada, Marta, Kosicka, Katarzyna, Siemiątkowska, Anna, Rudzki, Piotr J.

    “…•New FDA Guidance on bioanalytical method validation is similar to the EMA Guideline.•Differences include suggested validation parameters and terminology.•The…”
    Get full text
    Journal Article
  2. 2

    10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented? by Kaza, Michał, Sokolovskyi, Alexander, Rudzki, Piotr J.

    Published in Pharmaceutical research (01-07-2020)
    “…Purpose In 2010 the European Medicines Agency allowed a two-stage design in bioequivalence studies. However, in the public domain there are mainly articles…”
    Get full text
    Journal Article
  3. 3

    LC-MS/MS determination of dutasteride and its major metabolites in human plasma by Gniazdowska, Elżbieta, Kaza, Michał, Buś-Kwaśnik, Katarzyna, Giebułtowicz, Joanna

    “…Dutasteride is a specific and selective inhibitor of both 5α-reductase isoforms used mainly in benign prostatic hyperplasia and lower urinary tract symptoms…”
    Get full text
    Journal Article
  4. 4

    Visualizing bioanalytical methods – a near or distant future? by Kaza, Michał, Rudzki, Piotr J

    Published in Bioanalysis (01-04-2020)
    “…The latest US FDA guidance (1) and draft ICH M10 guideline (2) promote complementing analytical study reports with a trend graph for the quality control (QC)…”
    Get full text
    Journal Article
  5. 5

    Incurred Sample Reanalysis: Time to Change the Sample Size Calculation? by Rudzki, Piotr J., Biecek, Przemysław, Kaza, Michał

    Published in The AAPS journal (11-02-2019)
    “…Reliable results of pharmacokinetic and toxicokinetic studies are vital for correct decision making during drug discovery and development. Thus, ensuring high…”
    Get full text
    Journal Article
  6. 6

    Bioequivalence of Rivaroxaban Hard Capsules vs. Film-Coated Tablets in Healthy White Volunteers by Gierczak-Pachulska, Agnieszka, Kaza, Michał, Jarus-Dziedzic, Katarzyna, Czerepow-Bielik, Olga, Segiet-Święcicka, Agnieszka, Huszcza, Grzegorz, Sidoruk, Katarzyna, Rabczenko, Daniel, Rudzki, Piotr J.

    Published in Acta Poloniae pharmaceutica (01-04-2024)
    “…Rivaroxaban is an oral anticoagulant that is a selective, direct factor Xa inhibitor. It is used to prevent thrombotic events of atherosclerotic etiology and…”
    Get full text
    Journal Article
  7. 7

    Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol by Filist, Monika, Szlaska, Iwona, Kaza, Michał, Pawiński, Tomasz

    Published in Biomedical chromatography (01-06-2016)
    “…Estimating the influence of interfering compounds present in the biological matrix on the determination of an analyte is one of the most important tasks during…”
    Get full text
    Journal Article
  8. 8

    Comprehensive graphical presentation of data from incurred sample reanalysis by Rudzki, Piotr J, Biecek, Przemys aw, Kaza, Micha

    Published in Bioanalysis (01-06-2017)
    “…Incurred sample reanalysis (ISR) contributes to the reliability of pharmacokinetic studies. Despite regulatory guidelines having adopted ISR methodology,…”
    Get full text
    Journal Article
  9. 9

    Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysis by Rudzki, Piotr J, Kaza, Micha, Biecek, Przemys aw

    Published in Bioanalysis (01-02-2018)
    “…Incurred sample reanalysis (ISR) helps ensure the reliability of pharmacokinetic studies. An appropriate graph may facilitate the evaluation of an unmatched…”
    Get full text
    Journal Article
  10. 10

    HPLC-UV ASSAY OF IMATINIB IN HUMAN PLASMA OPTIMIZED FOR BIOEQUIVALENCE STUDIES by Kaza, Michal, Piorkowska, Edyta, Filist, Monika, Rudzki, Piotr J

    Published in Acta Poloniae pharmaceutica (01-11-2016)
    “…lmatimb is an anticancer drug approved for the treatment of a number of cancers, mostly used in chronic myeloid leukemia. Numerous bioanalytical methods using…”
    Get full text
    Journal Article
  11. 11

    Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine by Kaza, Michał, Gilant, Edyta, Filist, Monika, Szlaska, Iwona, Pawiński, Tomasz, Rudzki, Piotr J.

    Published in Clinical biochemistry (01-09-2014)
    “…Minimizing the impact of major or unstable metabolites on the determination of a drug substance represents a leading task in the development and validation of…”
    Get full text
    Journal Article
  12. 12

    Incurred sample reanalysis: adjusted procedure for sample size calculation by Rudzki, Piotr J, Bu -Kwa nik, Katarzyna, Kaza, Micha

    Published in Bioanalysis (01-11-2017)
    “…The incurred sample reanalysis (ISR) helps to assure bioanalysis reliability. The regulatory guidelines recommend the reanalysis of up to 10% of the study…”
    Get full text
    Journal Article
  13. 13

    Validated HPLC method for determination of temozolomide in human plasma by Gilant, Edyta, Kaza, Michał, Szlagowska, Anna, Serafin-Byczak, Krystyna, Rudzki, Piotr J

    Published in Acta Poloniae pharmaceutica (01-11-2012)
    “…The aim of the study was to develop a bioanalytical method for the determination of temozolomide (TMZ) in human plasma. Plasma concentration of TMZ was…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Bioequivalence study of 500 mg cefuroxime axetil film-coated tablets in healthy volunteers by Kaza, Michał, Leś, Andrzej, Serafin-Byczak, Krystyna, Ksycińska, Hanna, Rudzki, Piotr J, Gutkowskpi, Piotr, Drewniak, Tomasz, Gutkowska, Anna, Tarasiuk, Andrzej, Piatkowska-Chabuda, Ewa, Skowrońska-Smolak, Małgorzata, Wilkowska, Ewa

    Published in Acta Poloniae pharmaceutica (01-11-2012)
    “…The aim of the study was to investigate the bioavailability of a generic product of 500 mg cefuroxime axetil film-coated tablets (test) as compared to that of…”
    Get full text
    Journal Article